The Valiant Laboratories IPO commenced on September 27, 2023, and concluded on October 3, 2023. The allotment of shares took place on October 5, 2023, and the initiation of refunds began on October 5, 2023. The shares were credited to the demat accounts of investors on October 6, 2023. Finally, the listing of Valiant Laboratories on the stock exchange occurred on October 9, 2023.
The Valiant Laboratories IPO was priced at ₹133 to ₹140 per share, with a lot size of 105 shares. The total issue size was ₹152.46 crores, comprising a fresh issue of ₹152.46 crores. The IPO was listed on both the NSE and BSE.
In terms of quota reservations, the QIB (Qualified Institutional Buyers) quota was reserved for 75% of the shares, the NII (Non-Institutional Investors) quota was reserved for 15% of the shares, and the retail quota was reserved for 10% of the shares.
Valiant Laboratories IPO Basic Details
| Company Name | Valiant Laboratories Limited |
| Domain of Company | Pharmaceutical Company |
| Valiant Laboratories IPO GMP Today | ₹0.00 |
| Valiant Laboratories IPO Listing Gain | 0.00% |
| Valiant Laboratories IPO Open Date | September 27, 2023 |
| Valiant Laboratories IPO Close Date | October 3, 2023 |
| Valiant Laboratories IPO Allotment Date | October 5, 2023 |
| Valiant Laboratories IPO Listing Date | October 9, 2023 |
| Face Value | ₹10 per share |
| Price | ₹133 to ₹140 per share |
| Lot Size | 105 Shares |
| Issue Size | 10,890,000 shares of ₹10 (aggregating up to ₹152.46 Cr) |
| Fresh Issue | 10,890,000 shares of ₹10 (aggregating up to ₹152.46 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE, BSE |
| Company Promoters | Shantilal Shivji Vora, Santosh Shantilal Vora, and Dhanvallabh Ventures LLP (DVL) |
Valiant Laboratories IPO GMP Today:
| Date | GMP | Listing Gain | Kostak | Subject to |
| Today | ₹0 | 0.00% | – | – |
| 27 September 2023 | ₹0 | 0.00% | – | – |
Valiant Laboratories IPO Details:
Valiant Laboratories Limited, a pharmaceutical ingredient manufacturing company in India, was founded in 1980 with a primary focus on making Paracetamol.
Our manufacturing facility is situated in Palghar, Maharashtra, spanning 2,000 square meters of land. It has a total annual capacity of 9,000 metric tons. Additionally, we house an R&D Facility equipped with an analytical lab and the necessary infrastructure for developing existing products.
In the fiscal years 2023, 2022, and 2021, Valiant Laboratories recorded revenues of Rs. 3,339.10 million, Rs. 2,915.23 million, and Rs. 1,823.69 million, respectively.
To produce Paracetamol, Valiant Laboratories Limited imports Para Amino Phenol, a key raw material, from China and Cambodia.
As of April 30, 2023, our company employs 86 individuals.
Valiant Laboratories IPO More Details Click Here
Valiant Laboratories IPO FAQs
When is Valiant Laboratories IPO open?
Valiant Laboratories IPO will open on 27 September 2023.
When is Valiant Laboratories IPO Close?
Valiant Laboratories IPO will be closed on 3 October 2023.
What is Valiant Laboratories IPO GMP Today?
The Valiant Laboratories IPO GMP aka Grey Market Premium is ₹0.
What is Valiant Laboratories IPO Kostak Rates Today?
The Valiant Laboratories IPO Kostak Rate is ₹000.
What is Valiant Laboratories IPO Subject to Sauda Price Today?
The Valiant Laboratories IPO subject to sauda rates is ₹000.
Valiant Laboratories IPO Expected Returns?
The Valiant Laboratories expected return is 0.00%.
How much will be the listing gain in Valiant Laboratories IPO?
Valiant Laboratories IPO will get listing gain of 0.00%. (Approx.)
